Recruiting ENETS Research Projects

After a thorough selection process, ENETS Advisory Board has approved several research initiatives addressing so far unmet medical needs. ENETS is supporting the following trials, which are still recruiting.

ASPEN Study - Asymptomatic Small Pancreatic Endocrine Neoplasms.

A prospective evaluation of the management of Asymptomatic Sporadic nonfunctioning Pancreatic neuroEndocrine Neoplasms ≤ 2 cm

SEQTOR

The ongoing trial (SEQTOR) is currently investigating the antiproliferative efficacy and safety of everolimus, followed by STZ/5‐FU in advanced pancreatic NET (pNET) in a crossover design upon progression